ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
NCT07505849
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER_GOV
Sponsor class
Conditions
Follicular Lymphomas
Interventions
DRUG:
Zanubrutinib+R2
DRUG:
R2
Sponsor
KeshuZhou